These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1436074

  • 1. US drug trials said to ignore gender differences.
    Watson T.
    Nature; 1992 Nov 05; 360(6399):6. PubMed ID: 1436074
    [No Abstract] [Full Text] [Related]

  • 2. Gender differences in research.
    Rogers B.
    AAOHN J; 1994 Jan 05; 42(1):30-2. PubMed ID: 8147983
    [No Abstract] [Full Text] [Related]

  • 3. Drug interaction studies: study design, data analysis, and implications for dosing and labeling.
    Huang SM, Temple R, Throckmorton DC, Lesko LJ.
    Clin Pharmacol Ther; 2007 Feb 05; 81(2):298-304. PubMed ID: 17259955
    [Abstract] [Full Text] [Related]

  • 4. Clinical trial design issues in schizophrenic research.
    Casey DE.
    J Clin Psychiatry; 2001 Feb 05; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [Abstract] [Full Text] [Related]

  • 5. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E, Sapirstein W, Ahn C, Swain J, Zuckerman B.
    Ann Thorac Surg; 2006 Sep 05; 82(3):773-5. PubMed ID: 16928481
    [No Abstract] [Full Text] [Related]

  • 6. They are from the government and they really are here to help you.
    Woosley RL.
    J Clin Pharmacol; 2008 Feb 05; 48(2):142-3. PubMed ID: 18199889
    [No Abstract] [Full Text] [Related]

  • 7. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR, Orloff JJ.
    J Clin Pharmacol; 2008 Feb 05; 48(2):144-5. PubMed ID: 18199890
    [No Abstract] [Full Text] [Related]

  • 8. FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices.
    Goode J, Sapirstein W, Zuckerman B.
    Catheter Cardiovasc Interv; 2007 May 01; 69(6):920-1. PubMed ID: 17455345
    [No Abstract] [Full Text] [Related]

  • 9. Overhauling clinical trials.
    Scott CT, Baker M.
    Nat Biotechnol; 2007 Mar 01; 25(3):287-92. PubMed ID: 17344876
    [No Abstract] [Full Text] [Related]

  • 10. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW.
    Wall St J (East Ed); 2006 Jul 10; ():B1, B8. PubMed ID: 16858817
    [No Abstract] [Full Text] [Related]

  • 11. Understanding the biology of sex and gender differences: using subgroup analysis and statistical design to detect sex differences in clinical trials.
    Keitt SK, Wagner CR, Tong C, Marts SA.
    MedGenMed; 2003 Jun 09; 5(2):39. PubMed ID: 14603138
    [Abstract] [Full Text] [Related]

  • 12. When do differences in dissolution profiles predict clinical problems?
    Ngo SN.
    J Clin Pharm Ther; 2007 Apr 09; 32(2):111-2. PubMed ID: 17381660
    [No Abstract] [Full Text] [Related]

  • 13. Patient recruitment: US perspective.
    Walson PD.
    Pediatrics; 1999 Sep 09; 104(3 Pt 2):619-22. PubMed ID: 10469803
    [Abstract] [Full Text] [Related]

  • 14. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC, Cross JT.
    Clin Pharmacol Ther; 2007 Jul 09; 82(1):12-4. PubMed ID: 17571068
    [No Abstract] [Full Text] [Related]

  • 15. Females in clinical studies: where are we going?
    Uhl K, Parekh A, Kweder S.
    Clin Pharmacol Ther; 2007 Apr 09; 81(4):600-2. PubMed ID: 17314925
    [Abstract] [Full Text] [Related]

  • 16. Participation of women in clinical trials of drug therapies: a context for the controversies.
    Prout MN, Fish SS.
    Medscape Womens Health; 2001 Oct 09; 6(5):1. PubMed ID: 11698923
    [Abstract] [Full Text] [Related]

  • 17. How experimental drugs are tested in humans.
    Flieger K.
    Pediatr Infect Dis J; 1989 Mar 09; 8(3):160-2. PubMed ID: 2710587
    [No Abstract] [Full Text] [Related]

  • 18. Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials.
    Merkatz RB, Temple R, Subel S, Feiden K, Kessler DA.
    N Engl J Med; 1993 Jul 22; 329(4):292-6. PubMed ID: 8305004
    [No Abstract] [Full Text] [Related]

  • 19. When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective.
    Huang SM, Temple R, Xiao S, Zhang L, Lesko LJ.
    Clin Pharmacol Ther; 2009 Nov 22; 86(5):475-9. PubMed ID: 19844224
    [Abstract] [Full Text] [Related]

  • 20. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D.
    Science; 2008 Oct 24; 322(5901):516. PubMed ID: 18948510
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.